Neural Mechanisms of Anxiety During Early and Protracted Abstinence in Alcohol Use Disorder
Anxiety during abstinence in Alcohol Use Disorder
Sponsor: National Institutes of Health
Enrolling: Male and Female Patients
Study Length: 13 Weeks
IRB Number: AAAV4012
U.S. Govt. ID: NCT06793488
Contact: A. Benjamin Srivastava, MD: (646) 774-8189 / narrlab@cumc.columbia.edu
Additional Study Information: Columbia University Medical Center is recruiting individuals ages 21-40 who are seeking treatment for alcohol problems to participate in a research study involving treatment. For your participation, you'll receive treatment with disulfiram (brand name Antabuse) at no cost. You be treated with disulfiram for approximately 13 weeks and undergo brain scanning after 1 and 12 weeks of disulfiram treatment. You will be compensated up to $630 for completion of all study procedures.
Investigator
A. Benjamin Srivastava, MD
Do You Qualify?
Do you suffer from alcohol use disorder? Yes No
Are you seeking treatment? Yes No
Have you tried disulfiram (Antabuse) in the past? Yes No
Are you willing to undergo brain scanning? Yes No
Do you have major medical problems? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
A. Benjamin Srivastava, MD
narrlab@cumc.columbia.edu
(646) 774-8189
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE